WELCOME TO THE DIGITAL PROGRAM BOOKLET
IMPORTANT: The information below was self-reported by the presenters and is available to the Harvard University HIV research community to foster engagement and promote collaborative research among investigators. Poster Presentations will be staffed by the author team between 2:30 pm and 4:00 pm PT while Oral Presentations will occur at 10 am PT on the days indicated in the list below (scroll down to view).
Poster Presentations
| Name | Institutional Affiliation | Poster Title | Date & Time (PT) | Assigned Poster # | Funding Source |
|---|---|---|---|---|---|
| Amir Mohareb | Massachusetts General Hospital | Outcomes in HIV-Hepatitis B Coinfection Without Tenofovir-Containing Antiretroviral Therapy | Tuesday, 11 March at 2:30 pm | N/A | CFAR, NIAID |
| Borek Foldyna | Massachusetts General Hospital | Statin Effect Heterogeneity on Plaque Volume & Composition in the REPRIEVE Mechanistic Substudy | Wednesday, 12 March at 2:30 pm | 850 | NHLBI, NIAID – U01HL123336, U01HL123339, 1UG3HL164285, 1U24HL164284 |
| Caitlin Dugdale | Massachusetts General Hospital | Optimizing Investment in HIV Testing Services, ART, and PrEP to Reduce HIV Incidence in South Africa | Monday, 10 March at 2:30 pm | 1296 | NICHD, NIAID |
| Charles Crain | Ragon Institute of MGH, MIT and Harvard | Robust CD8+ T-Cell Proliferation and Stem-Like Memory Phenotype Linked to HIV Post-Treatment Control | Monday, 10 March at 2:30 pm | 405 | NIAID UM1AI164560 |
| David Collins | Ragon Institute of MGH, MIT and Harvard | 1) CD8+ T Cell Function During ART Is Associated With Provirus Suppression and Reduced Viral Rebound | Monday, 10 March at 2:30 pm | 403 | NIAID, HHMI |
| Deborah Kacanek | Harvard T.H. Chan School of Public Health | Childhood Exposure to Violence and Pregnancy-to-Postpartum Viral Load of US Women with HIV | Tuesday, 11 March at 2:30 pm | 992 | NICHD: P01HD103133, R01HD101351 and HD052102 ; NIMH, NIAID, NIDA, NIAAA, NHLBI, NIDCD, NINDS, NIDCR, NCI |
| Emily Hyle | Massachusetts General Hospital | 1) Model-Projected Costs Associated With Increasing Numbers of Medicare Beneficiaries With HIV Aged 65+ 2)The 10-year Prevalence of Hearing Loss and Dementia Among People with HIV in the United States | 1) Monday, 10 March 2:30 pm 2) Tuesday, 11 March at 2:30 pm | 1) 1291 2) 884 | 1) NIAID [R01 AI042006], NIAAA/NIAID/NCI/NIDA/NIDDK/NHLBI[U01 AI069918], NIA [R01 AG053100], NIA[R01 AG069575] 2) NIA [R01AG069575] |
| Emma Davies Smith | Harvard T.H. Chan School of Public Health | Time-Updated Win Ratio Aligns With Primary REPRIEVE Findings and Suggests Early Pitavastatin Benefit | Wednesday, 12 March at 2:30 pm | 853 | NHLBI, NIAID – U01HL123336, U01HL123339, 1UG3HL164285, 1U24HL164284 |
| Funsho Ogunshola | Ragon Institute of MGH, MIT and Harvard | Duration of Viremia Modulates Antigen Sensitivity of HIV-Specific T-Cell Receptors | Monday, 10 March at 2:30 pm | 2224 | CFAR, HHMI, Gate Foundation |
| Jennifer Manne-Goehler | Brigham and Women’s Hospital | Liraglutide for Obesity in HIV (LIROH): A Single-Arm, Open-Label Clinical Trial in South Africa | Monday, 10 March at 2:30 pm | 864 | NIDDK |
| John Chiosi | Massachusetts General Hospital | Cost-Effectiveness of PrEP and Medications for Opioid Use Disorder in People Who Inject Drugs | Monday, 10 March at 2:30 pm | 1294 | CFAR, NIAID P30 AI060354 |
| Karen Smith | Brigham and Women’s Hospital | Clinical and Economic Benefits of Preventing Physical Frailty and Falls Among PWH in the US | Tuesday, 11 March at 2:30 pm | 879 | National Institute of Nursing Research (R01AR080638) |
| Kenneth Freedberg | Massachusetts General Hospital | Ending the HIV epidemic among men who have sex with men in the United States: a modeling analysis | Monday, 10 March at 2:30 pm | 1295 | NIAID |
| Lauren Violette | Harvard Pilgrim Health Care Institute | 1) Preferences for HIV Testing Technologies in Seattle, Washington: A Mixed-Methods Study 2) Support for Over-the-Counter PrEP Among Transgender Women and Transfeminine Non-Binary People | 1) Wednesday, 12 March at 2:30 pm 2) Monday, 10 March at 2:30 pm | 1) 1195 2) 1204 | 1) CDC 2) NIMH |
| Manish Choudhary | Brigham and Women’s Hospital | SARS-CoV-2 Ensitrelvir resistance-associated mutations in Phase III randomized clinical trial | Wednesday, 12 March at 2:30 pm | 1) 713 2) G-05 | NIH |
| Maya Watanabe | Harvard TH Chan School of Public Health, Center for Biostatistics in AIDS Research | Heart Failure Risk and Events in People With HIV in the REPRIEVE Trial | Monday, 10 March at 2:30 pm | 818 | NHLBI, NIAID – U01HL123336, U01HL123339, 1UG3HL164285, 1U24HL164284 |
| Nicholas Venturelli | Boston Children’s Hospital | Low Rates of HIV Pre-Exposure Prophylaxis Prescriptions Among US Youth in a Claims Database | Tuesday, 11 March at 2:30pm | 1076 | T32 |
| Sampa Santra | Beth Israel Deaconess Medical Center | Unmodified mRNA compared to modified mRNA induces optimal CD8+ T cell responses in rhesus macaques | Monday, 10 March at 2:30 pm | 411 | NIAID |
| Sujata Tewari | Massachusetts General Hospital | LA-ART for Breastfeeding Women With HIV in Zimbabwe: Clinical Impact and Cost-Effectiveness | Monday, 10 March at 2:30 pm | 1) 1014 2) O-01 | NICHD |
| Suzanne McCluskey | Massachusetts General Hospital | HIV Drug Resistance by Next-Generation Sequencing After Transition to TLD in Uganda and South Africa | Wednesday, 12 March at 2:30 pm | 745 | NIAID K23AI143470 |
Oral Presentations
| Name | Institutional Affiliation | Oral Presentation Title | Date & Time (PT) | Funding Source |
|---|---|---|---|---|
| Alan Engelman | Dana Farber Cancer Institute | How HIV Integrates Into the Genome | Tuesday, March 11, 4 pm – 5:30 pm | N/A |
| David Collins | Ragon Institute of MGH, MIT and Harvard | HIV-Specific CD8+ T Cell Stemness Predicts Post-Intervention Control of Viremia | Tuesday, March 11 at 10am | NIAID; HHMI |
| Jeffrey Imai-Eaton | Harvard T.H. Chan School of Public Health | Immediate Challenges and Long-Term Goals of the HIV Response | Monday, March 10 at 4 pm | N/A |
| Jonathan Li | Brigham and Women’s Hospital | Game Changed: Navigating the Era of Long-Acting Therapies for HIV Prevention | Tuesday, March 11 at 4 pm | N/A |
| Josh Cyktor | Massachusetts General Hospital | Longitudinal Persistence of HIV DNA in CSF Over 4 Years Despite Up to 20 Years of ART | Wednesday, March 12 at 12 pm | N/A |
| Julia Marcus | Harvard Pilgrim Health Care Institute | Machine Learning: Gearing Up for the Future (Moderating this themed discussion session) | Tuesday, March 11, 1:30 pm – 2:30 pm | N/A |
| Mark Siedner | Massachusetts General Hospital | Epidemiology of Coronary Atherosclerosis Among People Living With HIV in Uganda | Wednesday, March 12, 10 am – 12:00 pm | NHLBI |
| Michael Traeger | Harvard Pilgrim Health Care Institute | Long-Acting Cabotegravir PrEP Uptake and Persistence in a Large US Healthcare System | Wednesday, March 12 at 10 am | N/A |
| Sara Looby | Massachusetts General Hospital | Clinical Management of Menopause in Women Living with HIV: “The best offense is good defense” | Tuesday, March 11, 4-5 pm | N/A |
| Steve Grinspoon | Massachusetts General Hospital | 1) Plaque, Inflammation, Subclinical Myocardial Injury and MACE in the REPRIEVE Mechanistic Substudy 2) Cardiometabolic Complications and Aging: The Clock is Ticking | 1) Wednesday, March 12, 10-12 pm 12) Wednesday, March 12, 10 am | N/A |